Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Pleural Diseases Market Size Shifted, And What Is the Outlook Through 2034?
In recent times, there has been steady growth in the market size of pleural diseases. Expected to rise from $4.86 billion in 2024 to $5.21 billion in 2025, the market is set to experience a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the historic period include an increased incidence of pleural effusion, heightened awareness about pleural diseases, a greater emphasis on early diagnosis, an expansion in the number of healthcare facilities, and an increase in clinical trials related to pleural diseases.
Expectations are high for robust expansion in the pleural diseases market in the following years, with an anticipated growth to$6.88 billion in 2029,” representing a compound annual growth rate (CAGR) of 7.2%. This predicted growth within the market during the forecasted period can be linked to a rise in occurrences of pleural diseases, an aging population, an uptick in occupational risks, an increased quantity of clinical trials, and the swelling number of diagnostic centers. The forecasted period is expected to witness trends such as advancements in diagnostic technology, progressive diagnostic tools, the inclusion of minimally invasive procedures, enhanced drug development strategies, and the emergence of telemedicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp
What Are the Core Growth Drivers Propelling the Pleural Diseases Market Forward?
The escalating rates of infectious diseases are predicted to propel the expansion of the pleural diseases market in the future. Infectious diseases, which encompass ailments induced by detrimental microorganisms like bacteria, viruses, fungi, or parasites, are becoming more rampant. Progressions in global travel, in conjunction with environmental modifications to human behavior, amplify the widespread nature of these infectious diseases. Unlike other diseases, bacterial pneumonia, tuberculosis, and viral infections could lead to pleural disease through instigation of inflammation, infection, or excessive fluid in the pleural cavity. For example, the National Library of Medicine, a famed medical library based in the US, reported in January 2023, that infectious diseases result in more than 52 million deaths every year, thereby jeopardizing half of the world’s total population. Moreover, each year, an estimated 14 million children below the age of five succumb to these diseases, with 70% of these fatalities being preventable via vaccinations. Consequently, the escalating rates of infectious diseases is a key factor accelerating growth in the pleural diseases market.
What Segment Types Define the Pleural Diseases Market Structure?
The pleural diseasesmarket covered in this report is segmented –
1) By Disease Type: Pleurisy; Pleural Effusion; Pneumothelioma; Mesothelioma; Other Disease Types
2) By Treatment Modalities: Medications; Thoracentesis And Pleurodesis; Minimally Invasive Interventions; Surgical Interventions
3) By Diagnostic Tools: Imaging Techniques; Molecular Diagnostics; Thoracoscopy; Pleuroscopy
4) By End User: Hospitals And Clinics; Diagnostic Centers; Research And Academic Institutions
Subsegments:
1) By Pleurisy: Acute Pleurisy; Chronic Pleurisy; Infectious Pleurisy; Non-infectious Pleurisy
2) By Pleural Effusion: Transudative Pleural Effusion; Exudative Pleural Effusion; Malignant Pleural Effusion; Parapneumonic Pleural Effusion; Hemothorax; Chylothorax
3) By Pneumothelioma: Primary Pneumothelioma; Secondary Pneumothelioma (Metastatic); Localized Pneumothelioma; Diffuse Pneumothelioma
4) By Mesothelioma: Pleural Mesothelioma; Peritoneal Mesothelioma; Pericardial Mesothelioma; Testicular Mesothelioma
5) Other Disease Types: Pulmonary Embolism; Fibrothorax; Pneumothorax; Lung Cancer; Tuberculosis-Related Pleural Disease; Sarcoidosis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Pleural Diseases Market?
North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing thePleural Diseases Industry Evolution?
Firms of significant stature in the pleural diseases market are directing their attention towards the creation of novel treatment propositions, including ready-to-use injectable treatments which amplify convenience, slice down the time taken for preparations, and mitigate inaccuracies in dosage. The ready-to-use injectable treatments are pre-diluted, pre-formulated medications that eliminate the necessity of reconstitution or mixing before they are administered, thereby enhancing accuracy, convenience, and trimming down the preparation time. A gelid example of this advancement is Amneal Pharmaceuticals, a company based in the USA, which initiated PEMRYDI RTU, the inaugural ready-to-use variant of pemetrexed for injection, in April 2024. This innovation aids those suffering from pleural diseases by offering a treatment that is ready-to-use, eliminating the need for dilution or reconstitution, bringing down the preparation time, diminishing the possibility of dosage errors, and augmenting access to proficient therapy for ailments such as malignant pleural mesothelioma.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report
What Is the Definition of the Pleural Diseases Market?
Pleural diseases refer to a group of conditions that affect the pleura, which is the double-layered membrane surrounding the lungs. These diseases can involve inflammation, infection, or other pathological pleural changes. Pleural diseases cause chest pain, shortness of breath, coughing, and difficulty breathing and are often diagnosed with imaging tests such as chest X-rays or CT scans.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model